Skip to main content
Premium Trial:

Request an Annual Quote

Novartis Opens Tropical Disease Institute in Singapore Biopolis

NEW YORK, July 5 (GenomeWeb News) - Novartis opened a tropical diseases research facility today in Singapore's Biopolis, which will initially focus on drug-resistant tuberculosis and dengue fever.


The Novartis Institute for Tropical Diseases, a joint venture of the Swiss pharmaceutical giant and the Singapore Economic Development board, has the goal of getting at least two vaccines into the clinic by 2008, and onto the market by 2013, Novartis said. The center will be funded with $162.2 million over the next eight years, according to Novartis.  


The institute first began operations last year. Over 70 scientists and 30 students are slated to be working at the institute by the end of 2004.


The drug discovery activities at the Novartis institute will involve development of screening assays and target discovery. Biopolis also houses a DNA sequencing facility.


The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.